Get started
Author

Miriana Cardano

Observed name: Cardano, Miriana
ORCID: 0000-0001-5027-1309
Observed ORCID: 0000-0001-5027-1309
OpenAlex ID: A5045344460
Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation
2020 · Miriana Cardano, Carla Tribioli, et al. · Current Cancer Drug Targets · 192
Sex disparities in DNA damage response pathways: Novel determinants in cancer formation and therapy
2022 · Miriana Cardano, Giacomo Buscemi, et al. · iScience · 41
PDF
R-loops and impaired autophagy trigger cGAS-dependent inflammation via micronuclei formation in Senataxin-deficient cells
2024 · Laura Zannini, Miriana Cardano, et al. · Cellular and Molecular Life Sciences · 17
PDF
CRISPR/Cas9 mediated Y-chromosome elimination affects human cells transcriptome
2024 · Ludovica Celli, Patrizia Gasparini, et al. · Cell & Bioscience · 16
PDF
Sex specific regulation of TSPY-Like 2 in the DNA damage response of cancer cells
2023 · Miriana Cardano, Martina Magni, et al. · Cell Death and Disease · 15
PDF
A proteasome-dependent inhibition of SIRT-1 by the resveratrol analogue 4,4′-dihydroxy-trans-stilbene
2024 · Vittoria Livraghi, Laura Mazza, et al. · Journal of Traditional and Complementary Medicine · 6
Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies
2025 · Miriana Cardano, Giacomo Buscemi, et al. · Cells · 4
TSPY-like 2, Beyond the Histone Chaperone Role
2026 · Emanuele Bonenti, Miriana Cardano, et al. · Biomolecules · 1
PDF
Stability of c-Myc Protein in Early S Phase Is Regulated by the Interaction with PCNA
2026 · Miriana Cardano, Ornella Cazzalini, et al. · International Journal of Molecular Sciences
PDF
Works count: 12
Citation count: 292
H-index: 6
I10-index: 5
Year
Topic
Type